Fisher & Paykel Healthcare (ASX:FPH) Short-Term Debt : A$80 Mil (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Fisher & Paykel Healthcare Short-Term Debt?

Fisher & Paykel Healthcare's Short-Term Debt for the quarter that ended in Sep. 2024 was A$80 Mil.

Fisher & Paykel Healthcare's quarterly Short-Term Debt increased from Sep. 2023 (A$22 Mil) to Mar. 2024 (A$73 Mil) and increased from Mar. 2024 (A$73 Mil) to Sep. 2024 (A$80 Mil).

Fisher & Paykel Healthcare's annual Short-Term Debt declined from Mar. 2022 (A$5 Mil) to Mar. 2023 (A$4 Mil) but then increased from Mar. 2023 (A$4 Mil) to Mar. 2024 (A$73 Mil).

Fisher & Paykel Healthcare Short-Term Debt Historical Data

The historical data trend for Fisher & Paykel Healthcare's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Short-Term Debt Chart

Fisher & Paykel Healthcare Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Short-Term Debt

Get a 7-Day Free Trial

78.50

11.02

4.94

3.91

72.82

Fisher & Paykel Healthcare Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Short-Term Debt	Get a 7-Day Free Trial															37.61	3.91	21.97	72.82	80.15

Fisher & Paykel Healthcare Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Fisher & Paykel Healthcare Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

FSPKF:USA FPH:New Zealand FPLB:Germany FPLB:Germany

Address

15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013

Website

https://www.fphcare.com

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.